Plasmodium vivax in the Democratic Republic of East Timor: Parasite prevalence and antifolate resistance-associated mutations

Acta Tropica

Volumn 115, Issue 3, 2010, Pages 288-292

  de Almeida, Afonso ^a,b   Rosário, Virgílio E do ^b   Henriques, Gisela ^b   Arez, Ana Paula ^b   Cravo, Pedro ^b  

^a Avenida Cidade de Lisboa   (Timor-Leste)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

Dhfr dhps; East Timor; Malaria; Plasmodium vivax; Sulfadoxine pyrimethamine

Indexed keywords

FANSIDAR; FOLIC ACID ANTAGONIST; ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PROTOZOAL DNA; PROTOZOAL PROTEIN;

DETECTION METHOD; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE RESISTANCE; DISEASE SPREAD; DISEASE VECTOR; GENOTYPE; HEALTH IMPACT; MALARIA; MUTATION; PARASITE; PATHOGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CASE FINDING; CHILD; CODON; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORBIDITY; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; TIMOR-LESTE; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; MALARIA, VIVAX; MIDDLE AGED; MISSENSE MUTATION; PARASITOLOGY; PREVALENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DNA, PROTOZOAN; DRUG RESISTANCE; EAST TIMOR; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; MUTATION, MISSENSE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROTOZOAN PROTEINS; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

LESSER SUNDA ISLANDS; SUNDA ISLES; TIMOR; TIMOR-LESTE;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 77953621993     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.04.008     Document Type: Article

References (23)

1. Alam M.T., Bora H., Bharti P.K., Saifi M.A., Das M.K., Dev V., Kumar A., Singh N., Dash A.P., Das B., Wajihullah, Sharma Y.D. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents Chemother. 2007, 51:857-863.
2. Auliff A., Wilson D.W., Russell B., Gao Q., Chen N., Anh le N., Maguire J., Bell D., O'Neil M.T., Cheng Q. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am. J. Trop. Med. Hyg. 2006, 75:617-621.
3. Brega S., de Monbrison F., Severini C., Udomsangpetch R., Sutanto I., Ruckert P., Peyron F., Picot S. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob. Agents Chemother. 2004, 48:2581-2587.
4. Chen N., Baker J., Ezard N., Burns M., Edstein M.D., Cheng Q. Short report: molecular evaluation of the efficacy of chloroquine treatment of uncomplicated Plasmodium falciparum malaria in East Timor. Am. J. Trop. Med. Hyg. 2002, 67:64-66.
5. de Almeida A., Arez A.P., Cravo P.V., do Rosário V.E. Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor. Malar. J. 2009, 8:59.
6. de Pécoulas P.E., Tahar R., Ouatas T., Mazabraud A., Basco L.K. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol. Biochem. Parasitol. 1998, 92:265-273.
7. de Pécoulas P.E., Tahar R., Yi P., Thai K.H., Basco L.K. Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia. Acta Trop. 2004, 92:1-6.
8. Ezard N., Burns M., Lynch C., Cheng Q., Edstein M.D. Efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum infection in East Timor, 2000. Acta Trop. 2003, 88:87-90.
9. Gregson A., Plowe C.V. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 2005, 57:117-145.
10. Hastings M.D., Maguire J.D., Bangs M.J., Zimmerman P.A., Reeder J.C., Baird J.K., Sibley C.H. Novel Plasmodium vivax dhfr alleles from the Indonesian archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. Antimicrob. Agents Chemother. 2005, 49:733-740.
11. Hastings M.D., Porter K.M., Maguire J.D., Susanti I., Kania W., Bangs M.J., Hopkins S.C., Baird J.K. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J. Infect. Dis. 2004, 189:744-750.
12. Imwong M., Pukrittakayamee S., Looareesuwan S., Pasvol G., Poirreiz J., White N.J., Snounou G. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 2001, 45:3122-3127.
13. Imwong M., Pukrittayakamee S., Cheng Q., Moore C., Looareesuwan S., Snounou G., White N.J., Day N.P. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob. Agents Chemother. 2005, 49:4393-4395.
14. Kaur S., Prajapati S.K., Kalyanaraman K., Mohmmed A., Joshi H., Chauhan V.S. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. Acta Trop. 2006, 97:174-180.
15. Kolaczinski J., Webster J. Malaria control in complex emergencies: the example of East Timor. Trop. Med. Int. Health. 2003, 8:48-55.
16. Leartsakulpanich U., Imwong M., Pukrittayakamee S., White N.J., Snounou G., Sirawaraporn W., Yuthavong Y. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol. Biochem. Parasitol. 2002, 119:63-73.
17. Ministry of Health, 2002. Health Profile Democratic Republic of Timor Leste.
18. Na B.K., Lee H.W., Moon S.U., In T.S., Lin K., Maung M., Chung G.T., Lee J.K., Kim T.S., Kong Y. Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay division, Myanmar. Parasitol. Res. 2005, 96:321-325.
19. Schunk M., Kumma W.P., Miranda I.B., Osman M.E., Roewer S., Alano A., Löscher T., Bienzle U., Mockenhaupt F.P. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Malar. J. 2006, 5:54.
20. Snounou G., Viriyakosol S., Jarra W., Thaithong S., Brown K.N. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol. Biochem. Parasitol. 1993, 58:283-292.
21. Tjitra E., Baker J., Suprianto S., Cheng Q., Anstey N.M. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob. Agents Chemother. 2002, 46:3947-3953.
22. Valecha N., Joshi H., Eapen A., Ravinderan J., Kumar A., Prajapati S.K., Ringwald P. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their pvdhfr gene mutation pattern. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:831-837.
23. WHO, 2008. World Malaria Report 2008. WHO Library Cataloguing-in-Publication Data. WHO, Geneva, ISBN 978 92 4 156396 7.